Literature DB >> 30429038

Examining the role of access to care: Racial/ethnic differences in receipt of resection for early-stage non-small cell lung cancer among integrated system members and non-members.

Devon K Check1, Kathleen B Albers2, Kanti M Uppal3, Jennifer Marie Suga4, Alyce S Adams5, Laurel A Habel6, Charles P Quesenberry7, Lori C Sakoda8.   

Abstract

OBJECTIVES: To examine the role of uniform access to care in reducing racial/ethnic disparities in receipt of resection for early stage non-small cell lung cancer (NSCLC) by comparing integrated health system member patients to demographically similar non-member patients.
MATERIALS AND METHODS: Using data from the California Cancer Registry, we conducted a retrospective cohort study of patients from four racial/ethnic groups (White, Black, Hispanic, Asian/Pacific Islander), aged 21-80, with a first primary diagnosis of stage I or II NSCLC between 2004 and 2011, in counties served by Kaiser Permanente Northern California (KPNC) at diagnosis. Our cohort included 1565 KPNC member and 4221 non-member patients. To examine the relationship between race/ethnicity and receipt of surgery stratified by KPNC membership, we used modified Poisson regression to calculate risk ratios (RR) adjusted for patient demographic and tumor characteristics.
RESULTS: Black patients were least likely to receive surgery regardless of access to integrated care (64-65% in both groups). The magnitude of the black-white difference in the likelihood of surgery receipt was similar for members (RR: 0.82, 95% CI: 0.73-0.93) and non-members (RR: 0.86, 95% CI: 0.80-0.94). Among members, roughly equal proportions of Hispanic and White patients received surgery; however, among non-members, Hispanic patients were less likely to receive surgery (non-members, RR: 0.93, 95% CI: 0.86-1.00; members, RR: 0.98, 95% CI: 0.89-1.08).
CONCLUSION: Disparities in surgical treatment for NSCLC were not reduced through integrated health system membership, suggesting that factors other than access to care (e.g., patient-provider communication) may underlie disparities. Future research should focus on identifying such modifiable factors.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Access to care; Cancer care; Disparities

Mesh:

Year:  2018        PMID: 30429038      PMCID: PMC6242353          DOI: 10.1016/j.lungcan.2018.09.006

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  38 in total

1.  Racial differences in the treatment of early-stage lung cancer.

Authors:  P B Bach; L D Cramer; J L Warren; C B Begg
Journal:  N Engl J Med       Date:  1999-10-14       Impact factor: 91.245

2.  Reasons for underuse of recommended therapies for colorectal and lung cancer in the Veterans Health Administration.

Authors:  Mary Beth Landrum; Nancy L Keating; Elizabeth B Lamont; Samuel R Bozeman; Barbara J McNeil
Journal:  Cancer       Date:  2011-11-09       Impact factor: 6.860

3.  A modified poisson regression approach to prospective studies with binary data.

Authors:  Guangyong Zou
Journal:  Am J Epidemiol       Date:  2004-04-01       Impact factor: 4.897

Review 4.  Understanding racial disparities in cancer treatment and outcomes.

Authors:  Arden M Morris; Kim F Rhoads; Steven C Stain; John D Birkmeyer
Journal:  J Am Coll Surg       Date:  2010-07       Impact factor: 6.113

5.  Waiting Time Intervals for Non-small Cell Lung Cancer Diagnosis and Treatment in Alberta: Quantification of Intervals and Identification of Risk Factors Associated with Delays.

Authors:  J O A Kim; F Davis; C Butts; M Winget
Journal:  Clin Oncol (R Coll Radiol)       Date:  2016-06-26       Impact factor: 4.126

6.  Cancer-specific mortality of Asian Americans diagnosed with cancer: a nationwide population-based assessment.

Authors:  Quoc-Dien Trinh; Paul L Nguyen; Jeffrey J Leow; Deepansh Dalela; Grace F Chao; Brandon A Mahal; Manan Nayak; Marianne Schmid; Toni K Choueiri; Ayal A Aizer
Journal:  J Natl Cancer Inst       Date:  2015-03-20       Impact factor: 13.506

7.  Are patients at Veterans Affairs medical centers sicker? A comparative analysis of health status and medical resource use.

Authors:  Z Agha; R P Lofgren; J V VanRuiswyk; P M Layde
Journal:  Arch Intern Med       Date:  2000-11-27

8.  Race and sex differences in the receipt of timely and appropriate lung cancer treatment.

Authors:  Lisa R Shugarman; Katherine Mack; Melony E S Sorbero; Haijun Tian; Arvind K Jain; J Scott Ashwood; Steven M Asch
Journal:  Med Care       Date:  2009-07       Impact factor: 2.983

9.  Social factors, treatment, and survival in early-stage non-small cell lung cancer.

Authors:  H P Greenwald; N L Polissar; E F Borgatta; R McCorkle; G Goodman
Journal:  Am J Public Health       Date:  1998-11       Impact factor: 9.308

10.  Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  John A Howington; Matthew G Blum; Andrew C Chang; Alex A Balekian; Sudish C Murthy
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

View more
  7 in total

Review 1.  Insurance Networks and Access to Affordable Cancer Care.

Authors:  Kenneth L Kehl; Nancy L Keating; Sharon H Giordano; Deborah Schrag
Journal:  J Clin Oncol       Date:  2019-12-05       Impact factor: 44.544

2.  Use of Positron Emission Tomography Imaging: Another Nonbiological Source of Racial Disparities in US Cancer Care.

Authors:  Aaron P Mitchell; Peter B Bach
Journal:  J Natl Cancer Inst       Date:  2020-12-14       Impact factor: 13.506

Review 3.  Disparities in Lung Cancer Treatment.

Authors:  Sharon Harrison; Julia Judd; Sheray Chin; Camille Ragin
Journal:  Curr Oncol Rep       Date:  2022-01-26       Impact factor: 5.075

4.  Racial and Other Healthcare Disparities in Patients With Extensive-Stage SCLC.

Authors:  Umit Tapan; Vanessa Fiorini Furtado; Muhammad Mustafa Qureshi; Peter Everett; Kei Suzuki; Kimberley S Mak
Journal:  JTO Clin Res Rep       Date:  2020-10-20

5.  Addressing Lung Cancer Screening Disparities: What Does It Mean to Be Centralized?

Authors:  Eduardo R Núñez; Matthew Triplette
Journal:  Ann Am Thorac Soc       Date:  2022-09

6.  Disparities in Receiving Guideline-Concordant Treatment for Lung Cancer in the United States.

Authors:  Erik F Blom; Kevin Ten Haaf; Douglas A Arenberg; Harry J de Koning
Journal:  Ann Am Thorac Soc       Date:  2020-02

7.  Survival of Black and White Patients With Stage IV Small Cell Lung Cancer.

Authors:  Huashan Shi; Kexun Zhou; Jordan Cochuyt; David Hodge; Hong Qin; Rami Manochakian; Yujie Zhao; Sikander Ailawadhi; Alex A Adjei; Yanyan Lou
Journal:  Front Oncol       Date:  2021-12-10       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.